Pliant Therapeutics (PLRX) Short Interest Ratio & Short Volume $1.62 -0.09 (-4.97%) As of 10:07 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Pliant Therapeutics Short Interest DataPliant Therapeutics (PLRX) has a short interest of 3.32 million shares. This marks a 1.22% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.7, indicating that it would take 2.7 days of the average trading volume of 1.66 million shares to cover all short positions.Current Short Interest3,320,000 sharesPrevious Short Interest3,280,000 sharesChange Vs. Previous Month+1.22%Dollar Volume Sold Short$5.15 millionShort Interest Ratio2.7 Days to CoverLast Record DateAugust 15, 2025Outstanding Shares61,388,000 sharesPercentage of Shares Shorted5.41%Today's Trading Volume23,598 sharesAverage Trading Volume1,664,509 sharesToday's Volume Vs. Average1% Short Selling Pliant Therapeutics? Sign up to receive the latest short interest report for Pliant Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPLRX Short Interest Over TimePLRX Days to Cover Over TimePLRX Percentage of Float Shorted Over Time Pliant Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 8/15/20253,320,000 shares $5.15 million +1.2%N/A2.7 $1.55 7/31/20253,280,000 shares $4.79 million +13.9%5.8%2.6 $1.46 7/15/20252,880,000 shares $4.00 million +5.5%N/A2.4 $1.39 6/30/20252,730,000 shares $3.17 million -18.8%4.8%2.3 $1.16 6/15/20253,360,000 shares $4.64 million -14.3%5.9%3.3 $1.38 5/31/20253,920,000 shares $5.41 million -22.2%6.9%3.2 $1.38 5/15/20255,040,000 shares $6.90 million -2.1%8.8%2.7 $1.37 4/30/20255,150,000 shares $8.19 million +1.2%N/A1.9 $1.59 4/15/20255,090,000 shares $7.43 million +15.4%8.9%1.9 $1.46 3/31/20254,410,000 shares $5.95 million +10.8%7.7%1.7 $1.35 Get the Latest News and Ratings for PLRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pliant Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 3/15/20253,980,000 shares $6.13 million +21.0%7.0%1.6 $1.54 2/28/20253,290,000 shares $11.32 million -7.1%5.8%1.5 $3.44 2/15/20253,540,000 shares $10.76 million -51.0%6.2%2.4 $3.04 1/31/20257,230,000 shares $77.72 million -4.1%N/A7.2 $10.75 1/15/20257,540,000 shares $95.23 million +5.2%N/A14.8 $12.63 12/31/20247,170,000 shares $94.43 million -0.7%N/A14.2 $13.17 12/15/20247,220,000 shares $96.03 million -0.3%N/A14.3 $13.30 11/30/20247,240,000 shares $99.91 million -0.7%N/A16 $13.80 11/15/20247,290,000 shares $90.61 million +1.0%N/A17.4 $12.43 10/31/20247,220,000 shares $101.59 million +3.9%N/A19.5 $14.07 10/15/20246,950,000 shares $97.30 million +2.7%N/A16.5 $14.00 9/30/20246,770,000 shares $75.89 million -7.3%N/A15.5 $11.21 9/15/20247,300,000 shares $87.60 million -0.4%N/A14.3 $12.00 8/31/20247,330,000 shares $97.42 million -0.1%N/A13.9 $13.29 8/15/20247,340,000 shares $91.24 million +4.3%N/A12.4 $12.43 7/31/20247,040,000 shares $100.74 million +1.2%N/A11.4 $14.31 7/15/20246,960,000 shares $92.08 million +0.6%N/A12.1 $13.23 6/30/20246,920,000 shares $74.39 million +4.7%N/A13.3 $10.75 6/15/20246,610,000 shares $78.00 million -0.8%N/A14.6 $11.80 5/31/20246,660,000 shares $80.79 million -4.2%N/A15.4 $12.13 5/15/20246,950,000 shares $106.75 million -8.0%N/A18.4 $15.36 4/30/20247,550,000 shares $89.24 million -0.9%N/A21.8 $11.82 4/15/20247,620,000 shares $103.25 million +2.1%N/A21.1 $13.55 3/31/20247,460,000 shares $111.15 million +6.6%N/A18.9 $14.90 3/15/20247,000,000 shares $106.33 million +2.0%N/A16.8 $15.19 2/29/20246,860,000 shares $108.87 million +1.5%N/A15.7 $15.87 2/15/20246,760,000 shares $113.57 million +8.9%N/A15.5 $16.80 1/31/20246,210,000 shares $111.28 million -2.5%N/A13.4 $17.92 1/15/20246,370,000 shares $114.02 million +0.8%N/A13.7 $17.90 12/31/20236,320,000 shares $114.46 million -0.6%N/A13.3 $18.11 12/15/20236,360,000 shares $106.59 million -1.6%N/A11.3 $16.76 11/30/20236,460,000 shares $89.73 million -1.1%N/A11.2 $13.89 11/15/20236,530,000 shares $88.81 million +3.0%N/A11.5 $13.60 10/31/20236,340,000 shares $93.01 million -2.2%N/A10.8 $14.67 10/15/20236,480,000 shares $98.82 million -6.2%N/A10.1 $15.25 9/30/20236,910,000 shares $119.82 million +9.5%N/A10.7 $17.34 9/15/20236,310,000 shares $101.02 million +4.3%N/A8.2 $16.01 8/31/20236,050,000 shares $102.12 million -2.4%N/A7.8 $16.88 8/15/20236,200,000 shares $111.17 million +5.3%N/A7.9 $17.93 7/31/20235,890,000 shares $105.08 million -1.7%N/A7 $17.84 7/15/20235,990,000 shares $109.62 million -6.0%N/A6.5 $18.30 6/30/20236,370,000 shares $115.42 million +12.5%N/A6.7 $18.12 6/15/20235,660,000 shares $132.39 million -4.9%N/A6.5 $23.39 5/31/20235,950,000 shares $128.70 million -3.4%N/A8.3 $21.63 5/15/20236,160,000 shares $137.55 million +48.4%N/A8.7 $22.33 4/30/20234,150,000 shares $117.24 million +7.8%N/A6.3 $28.25 4/15/20233,850,000 shares $102.03 million +7.2%N/A4.6 $26.50 3/31/20233,590,000 shares $95.49 million +26.4%N/A4.4 $26.60 3/15/20232,840,000 shares $78.19 million +2.5%N/A3.6 $27.53 2/28/20232,770,000 shares $88.25 million +10.8%N/A3.6 $31.86 2/15/20232,500,000 shares $78.28 million -7.4%N/A3.2 $31.31 1/31/20232,700,000 shares $94.61 million -18.9%N/A3.5 $35.04 1/15/20233,330,000 shares $78.06 million -10.0%N/A4.7 $23.44 12/30/20223,700,000 shares $71.52 million +26.3%N/A9.5 $19.33 12/15/20222,930,000 shares $56.90 million -10.7%N/A7.3 $19.42 11/30/20223,280,000 shares $60.29 million -12.8%N/A7.2 $18.38 11/15/20223,760,000 shares $81.52 million +1.6%N/A9.1 $21.68 10/31/20223,700,000 shares $92.02 million -1.9%N/A8.7 $24.87 10/15/20223,770,000 shares $85.13 million +9.6%N/A7.9 $22.58 9/30/20223,440,000 shares $71.86 million +8.9%N/A1.7 $20.89 9/15/20223,160,000 shares $75.46 million +4.6%N/A1.5 $23.88 8/31/20223,020,000 shares $58.23 million -5.6%N/A1.5 $19.28 8/15/20223,200,000 shares $69.47 million -3.3%N/A1.6 $21.71 7/31/20223,310,000 shares $57.49 million +28.8%9.5%1.7 $17.37 7/15/20222,570,000 shares $51.91 million +57.7%7.4%1.4 $20.20 6/30/20221,630,000 shares $13.06 million -21.6%6.1%1 $8.01 6/15/20222,080,000 shares $14.29 million -26.8%7.7%7.4 $6.87 5/31/20222,840,000 shares $15.99 million -10.4%10.6%13.2 $5.63 5/15/20223,170,000 shares $15.60 million +6.7%11.8%17.1 $4.92 4/30/20222,970,000 shares $17.40 million -5.1%11.1%18.9 $5.86 4/15/20223,130,000 shares $23.51 million +7.2%11.7%22.1 $7.51 3/31/20222,920,000 shares $20.47 million +9.8%10.9%22 $7.01 3/15/20222,660,000 shares $20.11 million +1.5%9.9%20.7 $7.56 2/28/20222,620,000 shares $23.50 million +6.5%9.8%17.2 $8.97 2/15/20222,460,000 shares $28.44 million +10.8%9.2%14.9 $11.56 1/31/20222,220,000 shares $26.04 million +6.2%8.3%14.3 $11.73 1/15/20222,090,000 shares $26.50 million +3.5%7.8%13.4 $12.68 12/31/20212,020,000 shares $27.27 million -8.6%7.5%14.2 $13.50 12/15/20212,210,000 shares $33.59 million -0.5%9.0%15.4 $15.20 11/30/20212,220,000 shares $31.48 million +11.0%9.0%18.6 $14.18 11/15/20212,000,000 shares $32.80 million +8.1%8.1%15 $16.40 10/29/20211,850,000 shares $29.47 million +1.7%7.5%14.6 $15.93 10/15/20211,820,000 shares $32.74 million -2.2%7.4%15.4 $17.99 9/30/20211,860,000 shares $31.40 million +2.2%7.6%15 $16.88 9/15/20211,820,000 shares $34.31 million -2.2%7.4%13.9 $18.85 8/31/20211,860,000 shares $33.93 million -1.1%7.6%14.3 $18.24 8/13/20211,880,000 shares $37.26 million -0.5%7.7%18.7 $19.82 7/30/20211,890,000 shares $38.18 million -0.5%7.7%18.1 $20.20 7/15/20211,900,000 shares $46.91 million +13.8%7.8%18 $24.69 6/30/20211,670,000 shares $48.63 million -4.0%6.8%15.1 $29.12 6/15/20211,740,000 shares $54.53 million -7.0%7.1%16.4 $31.34 5/28/20211,870,000 shares $56.21 million +4.5%7.7%12.3 $30.06 5/14/20211,790,000 shares $52.36 million -0.6%7.3%10.5 $29.25 4/30/20211,800,000 shares $60.03 million -4.3%7.4%10 $33.35 4/15/20211,880,000 shares $56.83 million +5.0%7.5%10.2 $30.23 3/31/20211,790,000 shares $66.21 million +26.1%7.2%10.2 $36.99 3/15/20211,420,000 shares $54.05 million +20.3%5.7%8.1 $38.06 2/26/20211,180,000 shares $46.89 million +13.5%4.8%9.6 $39.74 2/12/20211,040,000 shares $31.06 million +10.2%4.2%9.9 $29.87 1/29/2021943,800 shares $23.67 million -0.7%3.8%10.9 $25.08 1/15/2021950,800 shares $24.61 million No Change3.9%13.1 $25.88 PLRX Short Interest - Frequently Asked Questions What is Pliant Therapeutics' current short interest? Short interest is the volume of Pliant Therapeutics shares that have been sold short but have not yet been covered or closed out. As of August 15th, traders have sold 3,320,000 shares of PLRX short. Learn More on Pliant Therapeutics' current short interest. What is a good short interest ratio for Pliant Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PLRX shares currently have a short interest ratio of 3.0. Learn More on Pliant Therapeutics's short interest ratio. Which institutional investors are shorting Pliant Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Pliant Therapeutics: Group One Trading LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Pliant Therapeutics' short interest increasing or decreasing? Pliant Therapeutics saw a increase in short interest during the month of August. As of August 15th, there was short interest totaling 3,320,000 shares, an increase of 1.2% from the previous total of 3,280,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Pliant Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Pliant Therapeutics: CytomX Therapeutics, Inc. (15.24%), Aldeyra Therapeutics, Inc. (8.33%), Benitec Biopharma Limited (5.30%), Tonix Pharmaceuticals Holding Corp. (15.41%), 4D Molecular Therapeutics, Inc. (8.86%), Amarin Corporation PLC (2.06%), Candel Therapeutics, Inc. (17.84%), Capricor Therapeutics, Inc. (24.83%), Larimar Therapeutics, Inc. (7.12%), DiaMedica Therapeutics, Inc. (7.41%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Lucid Group, Inc. ($8.00 billion), Spotify Technology ($5.48 billion), AppLovin Corporation ($5.11 billion), Reddit Inc. ($5.02 billion), Coinbase Global, Inc. ($3.99 billion), Charter Communications, Inc. ($3.89 billion), Live Nation Entertainment, Inc. ($3.18 billion), Seagate Technology Holdings PLC ($2.59 billion), ResMed Inc. ($2.55 billion), and Rocket Lab Corporation ($2.52 billion). View all of the most shorted stocks. What does it mean to sell short Pliant Therapeutics stock? Short selling PLRX is an investing strategy that aims to generate trading profit from Pliant Therapeutics as its price is falling. PLRX shares are trading down $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Pliant Therapeutics? A short squeeze for Pliant Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PLRX, which in turn drives the price of the stock up even further. How often is Pliant Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PLRX, twice per month. The most recent reporting period available is August, 15 2025. More Short Interest Resources from MarketBeat Related Companies CytomX Therapeutics Short Interest Aldeyra Therapeutics Short Interest Benitec Biopharma Short Interest Tonix Pharmaceuticals Short Interest 4D Molecular Therapeutics Short Interest Amarin Short Interest Candel Therapeutics Short Interest Capricor Therapeutics Short Interest Larimar Therapeutics Short Interest DiaMedica Therapeutics Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PLRX) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...The Oxford Club | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWashington prepares for warWhile the headlines obsess over overseas conflicts, Washington has been quietly preparing for something much b...Porter & Company | SponsoredFree: The Crypto Summit That Could Change Your Life27 industry leaders share urgent market intel (free access)... For a very limited time, you can claim your ...Crypto 101 Media | SponsoredThis Massive Market is Ripe for Disruption by this NasdaqFanatics Hit $31B. This Nasdaq Company Is Building the Next Wave Fanatics built a merch empire by owning th...i2i Marketing Group, LLC | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pliant Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pliant Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
